|
28 Jun 2011 |
Sinovac Commences Phase II Clinical Trial for EV71 Vaccine
|
|
27 Jun 2011 |
PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
|
|
24 Jun 2011 |
Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
|
|
23 Jun 2011 |
GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine
|
|
23 Jun 2011 |
Diamyd Medical: Diamyd Initiates Closure of US Phase III study
|
|
21 Jun 2011 |
Mayo Clinic Researchers Use Human Vaccine to Cure Prostate Cancer in Mice
|
|
21 Jun 2011 |
Hemispherx Biopharma's Ampligen(R) Tested in Combination With Experimental Vaccine From Leading Cancer Research Institute
|
|
21 Jun 2011 |
NanoBio Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study
|
|
20 Jun 2011 |
Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan
|
|
20 Jun 2011 |
FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
|
|
16 Jun 2011 |
Novartis application for expanded Menveo(R) indication from 2 months of age accepted for review by FDA
|
|
16 Jun 2011 |
Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore
|
|
16 Jun 2011 |
BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine
|
|
14 Jun 2011 |
Arecor and GSK Form Collaboration to Advance New Vaccines
|
|
14 Jun 2011 |
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
|
|
13 Jun 2011 |
Circassia's Rapid Four-Dose ToleroMune Treatment Maintains Significant Reduction in Allergy Symptoms During 12-Month Follow-up
|
|
10 Jun 2011 |
The Juvenile Diabetes Research Foundation and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes
|
|
09 Jun 2011 |
ImmunoCellular Therapeutics Ltd. Expands Phase II Trial of ICT-107
|
|
09 Jun 2011 |
Isconova enters into adjuvant license agreement with Crucell
|
|
08 Jun 2011 |
Medicago reports positive U.S. clinical trial results for its H1N1 / seasonal influenza vaccine
|
|
08 Jun 2011 |
Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
|
|
08 Jun 2011 |
RXi Pharmaceuticals Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at ASCO
|
|
06 Jun 2011 |
Vaxart Begins First Oral Vaccine Clinical Trial
|
|
06 Jun 2011 |
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has begun dosing volunteers in a Phase I clinical trial
|
|
06 Jun 2011 |
BioSante Pharmaceuticals Announces Lifting of Clinical Hold on GVAX Prostate Cancer Vaccine
|
